About Conference

                

Why to attend Pathology 2025?

Session and Tracks

Track 1: Cancer Pathology

Metastasis, or metastatic disease, is the spread of cancer or other disease from one organ or part to another not directly connected with it. An oncovirus is a virus that can cause cancer. This term originated from studies of acutely transforming retroviruses in the 1950–60s, often called oncornaviruses to denote their RNA virus origin. Carcinogenesis or oncogenesis or tumorigenesis is the actual formation of cancer, whereby normal cells are transformed into cancer cells. Mutagenesis is a process by which the genetic information of an organism is changed in a stable manner, resulting in a mutation. It may occur spontaneously in nature, or as a result of exposure to mutagens. Apoptosis is a form of physiological cell death mediated by caspases, a unique family of intracellular cysteine proteases.

Track 2: Clinical Pathology

Clinical Pathology is a medical speciality that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids. Clinical Pathology is one of the major classifications of Pathology. Clinical Pathology is accomplished through a practical diagnosis of disease based on the laboratory analysis. Clinical Pathology is also useful in the diagnosis of recent out broken diseases like Zika fever which is caused by zika virus. Zika virus is transmitted to people primarily through the bite of an infected Aedes species mosquito. Clinical Pathology so far covers the diagnostic testing, Implications of cancer patients, Prognostic value, clinical and non-clinical toxicology testing, Clinical finding of cancer and other diseases. It emerges other subtopics like Neuropathology. The following topics are the latest research going on in Clinical Pathology. There are 36 associations and societies all over the world and 90 universities are working for clinical pathology. Companies/Laboratories like Clinical Pathology Laboratories and other diagnostics laboratories are leading in research of this clinical pathology and 3400 hospitals around USA are associated with pathology.

Track 3: Dermatopathology

Dermatopathology is a joint subspecialty of dermatology and pathology and to a lesser extent of surgical pathology that focuses on the study of cutaneous diseases at a microscopic and molecular level. It also encompasses analyses of the potential causes of skin diseases at a basic level. In fact, most of them are trained primarily in dermatology themselves. Dermatologists are able to recognize most skin diseases based on their appearances, anatomic distributions, and behaviour. Sometimes, however, those criteria do not allow a conclusive diagnosis to be made, and a skin biopsy is taken to be examined under the microscope or subject to other molecular tests. That process reveals the histology of the disease and results in a specific diagnostic interpretation. In some cases, additional specialized testing needs to be performed on biopsies, including immunofluorescence, immunohistochemistry, electron microscopy, flow cytometry, and molecular-pathologic analysis.

Track 4: Cytopathology and Histopathology

Cytopathology is a diagnostic technique that examines cells from various body sites to determine the cause or the nature of the disease. The first cytopathology test developed was the Pap test which has been widely utilized in the last 50 years for screening and diagnosing of cervical cancer and its precursors. The Pap test is considered the most successful screening test in medical history. Histopathology is the study of tissues (histology) and cells (cytology) and usually includes morbid anatomy (autopsies). Many refer to this speciality as Cellular Pathology. Histopathologists need good attention to detail for examining tissue and diagnosing disease. Histopathology involves the examination of sampled whole tissues under the microscope.

Track 5: Renal Pathology

The renal pathology research findings are associated with light microscopy, electron microscopy and immunofluorescence to obtain the accurate diagnosis. Renal Pathology or kidney pathology covers the topics toxic tubular necrosis, renal carcinomas, Diabetic glomerulosclerosis and other kidney related diseases examined under the microscope or molecular testing. Renal pathology in nephrology, toxins, tumors and Pathology of lupus glomerulonephritis are also very important to research topics for renal pathology. Medical renal diseases may affect the glomerulus, the tubules and interstitium, the vessels, or a combination of these compartments.

Track 6: Oral and Maxillofacial Pathology

Oral & Maxillofacial Pathology refers to the diseases of the mouth, jaws and related structures such as salivary glands, temporomandibular joints, facial muscles and perioral skin. It is a sub-speciality of both dentistry and Pathology or termed as head and neck pathology. It deals with the diagnosis and epidemiology of the disease. It Comprises of Microscopic diagnosis of biopsy specimens, Oral and Maxillofacial Surgery, Oral cancers, lesions and surgery in pediatric patients and reconstruction of maxillofacial defects. There are 36 associations and societies in USA and 18000 pathologists and 90 universities in USA. 1400 hospitals around USA associated with pathology.

Track 7: Veterinary Pathology

Veterinary Pathology is the study and diagnosis of animal disease by using animal tissue and fluids. Veterinary Pathology is classified into two main disciplines; those are veterinary anatomical pathology and veterinary clinical pathology. Veterinary Pathology deals with the following diseases like Veterinary parasite diseases and Veterinary parasitology whereas Veterinary clinical pathology deals with the diagnosis of disease based on the laboratory analysis. The American college of veterinary pathologists and European college veterinary pathologists are the main organizations working on pathology research and grants for the research. Veterinary pathology provides a critical link between the basic and clinical sciences. There are 10 main associations and societies in USA and approximately 60 universities around USA are associated with Veterinary Pathology.

Track 8: Molecular Pathology

Molecular pathology is an emerging discipline within pathology which is concentrated in the study and conclusion of ailment through the examination of molecules within organs, tissues or bodily fluids. Molecular pathology imparts a few parts of practice with drug development, disease management strategies and is sometimes considered a crossover discipline. It is multi-disciplinary in nature and concentrates primarily on the sub-minute parts of diseases. A key consideration is that more accurate diagnosis is possible when the diagnosis is based on both the morphologic changes in tissues and on molecular testing of diseases like cancer. In this sub-topics Molecular pathology is very useful in drug development and cancer. There are 5 associations and societies and the main association for Molecular Pathology is the Association of Molecular Pathology in USA. 78 universities are working on Molecular Pathology. Companies and hospitals around USA are associated with pathology. NIH has released $197,088 for Molecular Pathology research.

Track 9: Digital Pathology and e-Pathology

e-Pathology is defining the new paradigm of anatomic pathology. Telepathology image-based information sent to the far distance by telecommunication technology for research analysis in both academic and business side. e-Pathology is a complete scan of a microscopic glass slide and the viewing of the eSlide on a computer monitor through a digital software system. The researches in pathology look beyond the Advancements in diagnosis pathology by using the automated image analysis. The global digital pathology market, valued at $1.98 billion in 2012, is estimated to reach $5.7 billion by 2020. The Association of Digital Pathology is the main Association in Digital pathology field and conducts annual Pathology meetings. Ventana, Leica, Philips, GE Health care are the main competitors for Digital Pathology software updates and new releases.

Track 10: Surgical Pathology

Surgical pathology is the investigation of tissues expelled from living patients amid surgery to help analyze a malady and focus a treatment arrangement. Regularly, the surgical pathologist gives consultation benefits in a wide assortment of organ indications and subspecialties. Surgical pathologists give symptomatic data and/or second conclusions. Case in point, when performing breast cancer surgery, a surgical pathologist's examination of tissues separated during the surgery can help the specialist to figure out if to evacuate lymph nodes under the arm, also. Surgical pathology incorporates both the physical examination of the tissue with the bare eye and inspecting handled tissue under a magnifying instrument. There are 92 universities all over the USA where pathology research works are carried out in that main universities engaged in Surgical Pathology research are Stanford University of Medicine, John Hopkins University, Duke University and Washington University. National Institute of cancer has released $ 1,265,135 for Surgical Pathology research.

Track 11: Breast Pathology

Breast cancers can be divided into two main overarching groups: the carcinomas and the sarcomas. Carcinomas are cancers that arise from the epithelial component of the breast. The epithelial component consists of the cells that line the lobules and terminal ducts; under normal conditions, these epithelial cells are responsible for making milk. Carcinomas comprise the vast majority of all breast cancers and will be further discussed below. Sarcomas are rare cancers that arise from the stromal (connective tissue) components of the breast. These stromal component cells include myofibroblasts and blood vessel cells, and cancers arising from these "supportive" cells include phyllodes tumors and angiosarcoma. Sarcomas account for less than 1% of primary breast cancers.

Track 12: Hematopathology           

Hematopathology is a subspecialty of pathology. Hematopathology concern with the study of hematopoietic cells diseases and hematological disorders. A wide range of diagnosis test is done in Acute and chronic leukemia, Myelodysplastic syndromes, Myeloproliferative disorders, Anemias, Benign bone marrow and lymph node disorders, B-cell lymphomas and T-cell lymphomas and Cutaneous lymphomas. There are 89 universities all over the USA where pathology research works are carried out in that main universities engaged in Hematopathology research are the University of Texas MD Anderson cancer centre, Stanford University of Medicine, Yale University and Washington University. National Institute of cancer has released $540,054 for Hematopathology research.

Track 13: Microbial Pathology

A pathogen is a microorganism that is able to cause disease in a plant, animal or insect. Pathogenicity is the ability to produce disease in a host organism. Microbes express their pathogenicity by means of their virulence, a term which refers to the degree of pathogenicity of the microbe. Hence, the determinants of virulence of a pathogen are any of its genetic or biochemical or structural features that enable it to produce disease in a host.

Track 14: Gastrointestinal and Liver Pathology

Gastrointestinal pathology (including liver, gallbladder and pancreas) is a recognized sub-speciality discipline of surgical pathology. Recognition of a sub-speciality is generally related to dedicated fellowship training offered within the subspecialty or, alternatively, to surgical pathologists with a special interest and extensive experience in gastrointestinal pathology. The gastrointestinal (GI) pathology determines quality diagnostic histopathology on gastrointestinal endoscopic biopsies and resections of the gastrointestinal and pancreatico-biliary systems. Liver disease can occur through several mechanisms. A common form of liver disease is a viral infection. Viral hepatitides such as Hepatitis B virus and Hepatitis C virus can be vertically transmitted during birth via contact with infected blood.

Track 15: Anatomical Pathology

Anatomical pathology is the major speciality of pathology that deals with the study of the morphologic aspects of the disease. Anatomical Pathology concerns with the diagnosis of tissue and organ based macro or microscopic testing. The latest research undergoes from the following topics like Radiofrequency identification & specimen tracking, advanced biosafety practices, Multi-model anatomical pathology and Anatomical pathology of sexually transmitted diseases.  There are 36 associations and societies in USA and 18000 pathologists and 90 universities in USA. And 630 companies and 3400 hospitals around USA associated with pathology. The market revenue is expected to reach $74.65 billion by 2020 at a CAGR of 5.34% during 2014-2020. Diagnostic Medicine market growth rate is 5-7% yearly.

Market Analysis

Market Analysis of Pathology

The global digital pathology market, which was valued at $4.2 billion in 2023, has experienced significant growth and is estimated to reach $8.7 billion by 2030, demonstrating a Compound Annual Growth Rate (CAGR) of 14.3% during the period from 2025 to 2030. This growth is primarily attributed to the automation of testing procedures, leading to improved workflow efficiency and more accurate pathology tests.

The in vitro diagnostics market, which includes digital pathology, has experienced significant growth as well. In 2023, the market value was $73.32 billion, and it is projected to reach $114.65 billion by 2030, demonstrating a CAGR of 5.34% during the period from 2023 to 2030.

In the field of diagnostic medicine, there is a $35 billion market with annual growth rates of 5-7% . Pathology labs, a significant part of this industry, are expected to contribute approximately $15-16 billion in revenue, with around 12% of their revenues being spent on suppliers across the USA.

As of August 2023, there have been over 7000 licenses issued to pathology labs in the US. This includes approximately:

a. 1,600-1,700 commercial labs b. 3,300-3,400 hospital labs c. 1,800-1,900 physicians' office labs

Additionally, there are 130 medical schools and 155 training programs in the US, with a total of 59 universities in the country. Furthermore, there are 36 societies and associations related to pathology.

Digital Pathology Market

The global digital pathology market size is estimated to be worth USD 0.96 billion in 2024 and is anticipated to grow at a CAGR of 8.30% during the forecast period.

Pathology is a field of medical science that aids in the detection or recognition of diseases. Besides diagnosing diseases, pathology assists in examining nature, fluid, and cause of illness. In digital pathology, glass slides are converted into digital slides, connected to a virtual microscope and pathologists analyze the organ cells, interpret digital images of tissue samples through AI advanced hd imaging software and tools.

The market for digital pathology is projected to be accelerated by the increasing prevalence of chronic diseases and cancer which has boosted the demand for precise and timely pathology services. According to the National Cancer Institute, in 2023, around 2.0 million new cases of cancer were estimated to be diagnosed in the U.S.A. 15% of new breast cancer cases and 15% of prostate cancer were predicted to register. While, lung cancer was the most common cancer causing death with 21% of cases.  This spike in the growing incidence of cancer, due to the rise in geriatric population around the world, is anticipated to augment the demand for digital pathology service to overcome the workload of diagnosis tests.

In addition, the rising proliferation of advanced technology has boosted the adoption of AI based digital pathology services to improve the capacity of diagnostic, enhanced image analysis, and efficient workflows. Apart from accurate diagnostic competence, the advantages of digital pathology in improving the collaboration among different pathologists, ensuring long-term preservation of specimens and integrating artificial intelligence for automated analysis support the market demand. Furthermore, the market serves various stakeholders such as hospitals, healthcare institutions, diagnostic centers, laboratories and some other pharmaceutical companies which uplift the potential demand of the digital pathology service and solutions. Consequently, such key diving factors and diverse range of end user segments is likely to escalate the market growth with exceptional CAGR during this forecast period. 

Digital Pathology Market Outlook from 2023 to 2033

The digital pathology market size is projected to be worth US$ 7,035.8 million in 2023. The market is likely to reach US$ 24,961.8 million by 2033. The market is further expected to surge at a CAGR of 13.5% during the forecast period 2023 to 2033.

Key Market Trends and Highlights

• Digital pathology streamlines workflow, reduces turnaround times, and minimizes errors associated with manual processes. The efficiency improvement is a strong driver for adoption.
• Digital pathology plays a crucial role in drug discovery and research, enabling pharmaceutical companies to analyze tissue samples more effectively and efficiently.
• The globalization of healthcare services has increased the demand for remote consultation and second opinions. Digital pathology facilitates cross-border collaborations and consultations.
• Some governments and healthcare organizations are actively promoting the adoption of digital pathology to enhance healthcare infrastructure and improve patient outcomes.
• The shift toward patient-centric care requires more precise diagnoses and tailored treatment plans. Digital pathology can support this trend by providing comprehensive and accurate pathology data

Young Scientist Award

Prestigious Award for Young Researchers in Pathology 2025 - " Pathology and Pathological Disorders putting you a step ahead of disease" The Pathology Committee 2025 is pleased to announce the "Pathology and Pathological Disorders" in Madrid, Spain with the theme: “Explore the future of Medicinal and Pharmaceutical Science”. The Pathology Conference program deals with strategic discussions.

Pathology 2025 Young Scientist Awards: Committee

Pathology 2025 aims to recognize a prestigious award for young researchers, scientists, early career researchers, postgraduates, postdocs, interns and talented young professionals in recognition of their outstanding contribution to the conference theme. The Young Scientist Awards strive to provide young academics with strong professional development opportunities by meeting with experts to exchange and share their experiences on all aspects of Pathology.

Young Research`s Awards at Pathology 2025 for the nomination: Young Researcher Forum Outstanding Masters / Ph.D./Postdoctoral thesis presentation, only 25 accepted presentations at the Young Research Forum Pathology 2025.

Benefits of Best Young Scientist Award are:

• Young Scientist Award Certificate of recognition and reminder of the winners.
• Our conferences offer the best platform for your research through oral presentations.
• Learn about career enhancement with the latest technologies over networks.
• Young scientists are informed in a timely and adequate manner through this forum.
• Platform for young researchers working together for better development.
• Provide the opportunity to interact with established senior research and researchers around the world in the field.
• Share ideas with leading researchers and mentors

It is a great privilege for young researchers to know the research areas to expand their research knowledge.

Eligibility to participate

• Young scientists, postgraduates, postdocs, interns, junior professors
• The presentation must take place in the scientific sessions of the congress.
• Each Young Researcher / Young Scientist can only submit one paper (as first or co-author).
• Age limit under 35
• All submissions must be in English

Visa process

Visa Application Documents You should only apply for business visas to attend and attend conferences. Contact your nearest London, UK Travel Agency/Visa Information Center/Embassy for the correct application form.

All visas for the visit to London, UK are processed by the respective embassy authorities in the correct way only after the presentation of the corresponding documents.

If  no documents are provided or if the guidelines are not followed, the competent authorities hold the right to reject/cancel the visas.

The minimum documents that may be required when applying for the visa from / Rome, Italy include:

• Official Letter of Invitation
• Letter of Acceptance/Approval for abstracts (if you are a speaker)
• Proof of payment receipt for registration
• Hotel Booking Confirmation Letter for accommodation issued on conference letterhead

Note: For the Letter of Invitation and Accommodation Confirmation, payment of registration and accommodation fees is a prerequisite. Please contact us for more information